Abstract：This study is aim to determine the predominant prevailing nontuberculosis mycobacteria (NTM) in Hangzhou and to understand the predisposing factors and drug resistance of NTM. PNB/TCH growth tests were used to preliminarily identify the NTM in the mycobacterium-positive culture samples from 1 972 patients. The species of NTM isolates were confirmed using mycobacterium molecular linear probe method and sequencing of PCR product of 16S rRNA gene. The influence of sex and age on predisposing factors of NTM was subsequently analyzed. Concentration proportional method was applied to detect the susceptibility of NTM isolates to armazide, rifampicin, streptomycin, ethambutol, ofloxacin and kanamycin. Results of PNB/TCH growth tests showed that 9.8% (193/1 972) of the 1 972 mycobacterium-positive culture samples were positive. The mycobacterium molecular linear probe hybridization and PCR product sequencing confirmed that in the 193 samples with positive results of PNB/TCH growth tests, 66.3%, 18.1%, 8.3% and 7.3% were infected with NTM alone, two mycobacteria, Mycobacterium tuberculosis and bacteria that not belonging to the genus of Mycobacteria, respectively. In the 173 NTM isolates (128 with single infection and 45 with mixed infection), 57.8% were identified as Mycobacterium intracellulare, followed by Mycobacterium abscessus (12.1%), Mycobacterium kansasii (9.8%), Mycobacterium chelonei (9.8%) and Mycobacterium avium (5.8%). In the 35 mixed infection samples, 28.5% and 20.0% were the co-infection of M. intracellulare and M. chelonei with M. tuberculosis, respectively. Male patients infected with NTM were more than female patients (1.67:1) and the infection rate (80.4%) of populations with age over 50 years old was significantly high than that with lower than 50 years old (P<0.01). Pulmonary infection proportion (95.1%) of NTM was significantly higher than other positions of body (P<0.01). 100% of NTM isolates were resistant to armazide while the resistance rates of the isolates against the other 5 antituberculosis drugs were as high as 70.3%-90.6%. As the conclusion of this study, M. intracellulare is the predominant prevailing NTM species in the recent years in Hangzhou, NTM mainly causes pulmonary infection and middle-aged and old people are easily infected by NTM. Moreover, NTM isolates have high resistance against commonly used antituberculosis drugs.
吴亦斐, 刘伟, 谢捷, 吴琍敏, 王乐, 陆敏, 孙爱华, 谢立. 杭州地区流行非结核分枝杆菌鉴定、易感因素和耐药性分析[J]. 中国人兽共患病学报, 2017, 33(10): 882-887.
WU Yi-fei, LIU Wei, XIE Jie, WU Li-min, WANG Le, LU Min, SUN Ai-hua, XIE Li. Identification of predominant prevailing nontuberculosis mycobacteria in Hangzhou and analysis of their predisposing factors and drug resistance. Chinese Journal of Zoonoses, 2017, 33(10): 882-887.
[1] Cassidy PM, Hedberg K, Saulson A, et al. Nontuberculous mycobacteria disease prevalence and risk factors: a changing epidemiology[J]. Clin Infect Dis, 2009, 49(12): 124-129. doi:10.1086/648443 [2] Liu G, Wang Q, Han XH, et al. Analysis of drug susceptibility test results in 110 cases of NTM[J]. Chin J Tuberc Respir Dis, 2012, 35(8): 616-617. doi:10.3760/cma.j.issn.1001-0939.2012.08.016 (in Chinese) 刘刚,王庆,阚晓红,等. 非结核分枝杆菌110株的耐药性结果分析 [J]. 中华结核和呼吸杂志,2012, 35(8):616-617. [3] Luo CM, Zou GM, Liu GB, et al. Analysis on non-tuberculous mycobacteria identification in Guangzhou during 2003-2012[J]. J Tuberc Lung Health, 2014, 3(1): 15-20. doi:10.3969/j.issn.2095-3755.2014.01.004 (in Chinese) 罗春明,邹桂敏,刘国标,等. 广州市2003-2012年非结核分枝杆菌菌种鉴定结果分析 [J]. 结核病与肺部健康杂志,2014, 3(1):15-20. [4] Lai CC, Tan CK, Chou CH, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008[J]. Emerg Infect Dis, 2010, 16(2): 294-296. doi:10.3201/eid1602.090675 [5] Yoo JW, Jo KW, Kim MN, et al. Increasing trend of isolation of nontuberculous mycobacteria in a tertiary university hospital in South Korea[J]. Tuberc Respir Dis, 2012, 72(5): 409-415. doi:10.4046/trd.2012.72.5.409 [6] Chinese Antituberculosis Association. Rules for laboratory examination of tuberculosis[M]. Beijing:People’s Medical Publishing House, 2015:45-51. (in Chinese) 中国防痨协会. 结核病实验室检验规程 [M]. 北京:人民卫生出版社,2015:45-51. [7] Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual[M]. 2nd edition, New York: Cold Spring Harbor Laboratory Press, 1989: 1.21-1.52, 2.60-2.80, 7.3-7.35, 9.14-9.22. [8] Chinese Antituberculosis Association. Rules for laboratory examination of tuberculosis[M]. Beijing:People’s Medical Publishing House, 2015:59-87. (in Chinese) 中国防痨协会. 结核病实验室检验规程 [M]. 北京:人民卫生出版社,2015:59-87. [9] Liang L, Zhang YR, Yue J, et al. Susceptibility pattern and epidemiology of nontuberculous mycobacteria in Shanghai[J]. Chin J Nosocomiol, 2007, 17(7): 895-897. doi:10.3321/j.issn:1005-4529.2007.07.054 (in Chinese) 梁莉,张滢蓉,乐军,等. 上海市非结核分枝杆菌感染趋势及耐药分析 [J]. 中华医院感染学杂志,2007, 17(7):895-897. [10] Huang MX, Wan KL, Chen LZ, et al. Distribution of nontuberculous mycobacteria of clinical mycobacterium isolates from Fujian Province, China[J]. Chin J Zoonoses, 2014, 30(12): 1227-1230. doi:10.3969/j.issn.1002-2694.2014.12.012 (in Chinese) 黄明翔,万康林,陈力周,等. 福建省临床分离非结核分枝杆菌菌种分布研究 [J]. 中国人兽共患病学报,2014, 30(12):1227-1230. [11] Technical Guidance Group of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010[J]. Chin J Antituberc, 2012, 34(8): 485-508. (in Chinese) 全国第五次结核病流行病学抽样调查技术指导小组. 2010年全国第五次结核病流行病学抽样调查报告 [J]. 中国防痨杂志,2012, 34(8):485-508. [12] Yu XL, Xu LF, Zhu J, et al. Analysis of strain identification and drug susceptibility test results in 99 cases of NTM[J]. Chin J Health Lab Tec, 2015, 25(20): 3580-3582. (in Chinese) 余旭良,徐礼锋,祝进,等. 99株非结核分枝杆菌菌种鉴定和药敏结果分析 [J]. 中国卫生检验杂志,2015, 25(20):3580-3582. [13] Wang HX, Yue J, Han M, et al. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008[J]. Chin Med J, 2010, 123(2): 184-187. doi:10.3760/cma.j.issn.0366-6999.2010.02.011 [14] Hoefsloot W, Van IJ, Andrejak C, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: A NTM-NET collaborative study[J]. Eur Respir J, 2013, 42(6): 1604-1613. doi:10.1183/09031936.00149212 [15] Herdman AV, Steele JC Jr. The new mycobacterial species-emerging or newly distinguished pathogens[J]. Clin Lab Med, 2004, 24(3): 651-690. doi:10.1016/j.cll.2004.05.011 [16] Jing H, Wang Y, Li XX, et al. Distribution of nontuberculous mycobacteria in Shandong province[J]. Chin J Antituberc, 2009, 31(5): 273-276. (in Chinese) 景辉,王燕,李欣欣,等. 山东省非结核分枝杆菌感染的菌种分布研究 [J]. 中国防痨杂志,2009, 31(5):273-276. [17] Simons S, Van IJ, Hsueh PR, et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia[J]. Emerg Infect Dis, 2011, 17(3): 343-349. doi:10.3201/eid1703.100604
2017, Vol. 33 
